|
|
| | 1H-Pyrrolo[2,3-c]pyridine-2-carboxamide, 4-[5-(2,6-dimethylphenoxy)-2-(2-hydroxy-2-methylpropyl)-2H-indazol-6-yl]-N-ethyl-6,7-dihydro-6-methyl-7-oxo- Basic information |
| | 1H-Pyrrolo[2,3-c]pyridine-2-carboxamide, 4-[5-(2,6-dimethylphenoxy)-2-(2-hydroxy-2-methylpropyl)-2H-indazol-6-yl]-N-ethyl-6,7-dihydro-6-methyl-7-oxo- Chemical Properties |
| Boiling point | 747.9±60.0 °C(Predicted) | | density | 1.29±0.1 g/cm3(Predicted) | | pka | 13.51±0.40(Predicted) |
| | 1H-Pyrrolo[2,3-c]pyridine-2-carboxamide, 4-[5-(2,6-dimethylphenoxy)-2-(2-hydroxy-2-methylpropyl)-2H-indazol-6-yl]-N-ethyl-6,7-dihydro-6-methyl-7-oxo- Usage And Synthesis |
| Uses | BRD4-BD1/2-IN-2 is a potent BRD4 BD2 inhibitor with IC50s of <0.5 nM and <300 nM for BRD4 BD2 and BRD4 BD1, respectively (WO2021233371A1, compound 2)[1]. | | References | [1] Compound functioning as bromodomain protein inhibitor, and composition. WO2021233371A1. |
| | 1H-Pyrrolo[2,3-c]pyridine-2-carboxamide, 4-[5-(2,6-dimethylphenoxy)-2-(2-hydroxy-2-methylpropyl)-2H-indazol-6-yl]-N-ethyl-6,7-dihydro-6-methyl-7-oxo- Preparation Products And Raw materials |
|